Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions

Recent technological breakthroughs in medicinal chemistry arena had ameliorated the perspectives of quantitative structure–activity relationship (QSAR) methods. In this direction, we developed a group-based QSAR method based on pharmacophore-similarity concept which takes into account the 2D topological pharmacophoric descriptors and predicts the group-specific biological activities. This activity prediction may assist the contribution of certain pharmacophore features encoded by respective fragments toward activity improvement and/or detrimental effects. We termed this method as pharmacophore-similarity-based QSAR (PS-QSAR) and studied the activity contribution of fragments from 3-hydroxypyridinones derivatives possessing antimalarial activities.

[1]  P. Dobbin,et al.  The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. , 1991, Blood.

[2]  H. Kubinyi.  QSAR : Hansch analysis and related approaches , 1993 .

[3]  H. Pandya,et al.  Structural insights into the theoretical model of Plasmodium falciparum NADH dehydrogenase and its interaction with artemisinin and derivatives: towards global health therapeutics. , 2013, Omics : a journal of integrative biology.

[4]  H. Pandya,et al.  Evolutionary and Molecular Aspects of Indian Tomato Leaf Curl Virus Coat Protein , 2012, International journal of plant genomics.

[5]  Thierry Langer,et al.  Pharmacophores and Pharmacophore Searches: LANGER: PHARMACOPHORES AND PHARMACOPHORE SEARCHES O-BK , 2006 .

[6]  Karl Pearson F.R.S..  LIII. On lines and planes of closest fit to systems of points in space , 1901 .

[7]  K. Roy,et al.  Further exploring rm2 metrics for validation of QSPR models , 2011 .

[8]  Gert Vriend,et al.  Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.

[9]  J. Gasteiger,et al.  Chemoinformatics: A Textbook , 2003 .

[10]  Malcolm J. McGregor,et al.  Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design , 1999, J. Chem. Inf. Comput. Sci..

[11]  Mohsen Shahlaei,et al.  Stepwise MLR and PCR QSAR study of the pharmaceutical activities of antimalarial 3-hydroxypyridinone agents using B3LYP/6-311++G** descriptors , 2012, Medicinal Chemistry Research.

[12]  Sudhir A. Kulkarni,et al.  Group‐Based QSAR (G‐QSAR): Mitigating Interpretation Challenges in QSAR , 2009 .

[13]  H. Kubinyi.  QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .

[14]  L. Wang,et al.  Fragment-similarity-based QSAR (FS-QSAR) algorithm for ligand biological activity predictions , 2011, SAR and QSAR in environmental research.

[15]  M. Shahlaei,et al.  QSAR study of some 5-methyl/trifluoromethoxy- 1H-indole-2,3-dione-3-thiosemicarbazone derivatives as anti-tubercular agents , 2009, Research in pharmaceutical sciences.

[16]  D. Kyle,et al.  Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum. , 2001, The Southeast Asian journal of tropical medicine and public health.

[17]  Louis Cohen,et al.  Practical Statistics for Students , 1996 .

[18]  Bernard Testa,et al.  QSAR: Hansch analysis and related approaches , 1995 .

[19]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[20]  C. Hansch,et al.  Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. , 2001, Chemical reviews.

[21]  P. Willett,et al.  PHARMACOPHORE PERCEPTION , DEVELOPMENT , AND USE IN DRUG DESIGN , 2011 .

[22]  R. Hider,et al.  Basic 3-hydroxypyridin-4-ones: potential antimalarial agents. , 2008, European journal of medicinal chemistry.

[23]  Teodorico C. Ramalho,et al.  Molecular modeling of the Toxoplasma gondii adenosine kinase inhibitors , 2012, Medicinal Chemistry Research.

[24]  Sivakumar Prasanth Kumar,et al.  Design, Synthesis, Biological Evaluation, and Molecular Modeling of Coumarin–Piperazine Derivatives as Acetylcholinesterase Inhibitors , 2013, Archiv der Pharmazie.

[25]  Sérgio M. Marques,et al.  Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs , 2012 .

[26]  R. Lesyk,et al.  Biologically active 4-thiazolidinones: a review of QSAR studies and QSAR modeling of antitumor activity. , 2013, Current topics in medicinal chemistry.

[27]  Peter J. A. Shaw,et al.  Multivariate Statistics for the Environmental Sciences , 2003 .

[28]  William J. Welch,et al.  Computer-aided design of experiments , 1981 .